Navigation Links
POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events, including those discussed herein and in our Quarterly Report on Form 10-Q for the period ended September 30, 2006. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.

Contact

POZEN Inc.
Bill Hodges, 919-913-1030
Chief Financial Officer
or
Fran Barsky, 919-913-1044
Director, Investor Relations


'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: POZEN Announces Positive Outcome for Proof Concept Study
(Date:11/6/2009)...ewswire/ -- NexBio Inc., in collaboration with sci...vention (CDC), St. Louis University, and the Unive...n of two articles in the peer-reviewed journal PLo...AS181 (Fludase ® ) may play a potentially imp...e Pandemic Influenza A(H1N1) and drug-resistant in...
(Date:11/6/2009)... , - Trial Will Compare NX...atment of Multi-Resistant Staphylococcus Aureus (M...harmaceutical company focused on the discovery and...come the significant global,problem of microbial r...oral,antibacterial NXL103 (flopristin/linopristin)...
(Date:11/5/2009)..., Nov. 5 Transcept Pharm...rmaceutical company focused on the development and...dress important therapeutic needs in the field of ...st and teleconference with management to discuss t...ovember 12, 2009, at 5:00 p.m. Eastern Standard Ti...
Breaking Medicine Technology:NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2CCA Industries Inc Reports Second Quarter Earnings and Dividend for the Third Quarter 51512 1CCA Industries Inc Reports Second Quarter Earnings and Dividend for the Third Quarter 51512 2Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 1Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 2Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 3Diabetes Advocates Call For National Strategy Leadership to Reduce Diabetes and Advance Detection and Treatment 51510 4Olympus Managed Health Care Appoints Robert Lavers as Senior Consultant 51508 1Olympus Managed Health Care Appoints Robert Lavers as Senior Consultant 51508 2
....D., Ph.D. Contributing Editor Harvard Medical Sch...ilure in African American patients has underscored...ntly to the same medication. This concept holds t...d in many cases is due to individual genetic varia... these issues, valuable new laboratory tools have ...
...ributing Editor The first human case of West Nile ... in Kansas in late June. The CDC has released few...ng 2005,s first documented incidence of the mosqui... single-stranded RNA flavivirus of about 11 kb. I...ans, horses, and other vertebrates serving as inci...
Other Medicine Technology:Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 2Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy. 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 2West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 3West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak 4
(Date:11/7/2009)...eges fight back to stem a growing problem across t...ws) -- Nearly half of students at four-year colleg...it,s binge drinking -- downing five or more alcoho...e identifying alcohol as a drug," said Jenny Hwang...ounseling center at Stony Brook University on Long...
(Date:11/7/2009)... Forget ‘sweatox&rsquo...in the UK is the usage of the anti-ageing jab &lsq... when injected into the décolletage, can re...en the chest area around the breasts, leaving smoo... (PRWEB) November 7, 2009 -- Transform, the UK...
(Date:11/6/2009)...LANTA, Nov. 6 Recently a Narconon of Georgia grad...xperience with prescription drug abuse. The specia...ption drug addiction . In the report Andrew sh... more should be done to prevent prescription drug ...ing I knew I opened my eyes to my father on top of...
(Date:11/6/2009)...ITE PLAINS, N.Y., Nov. 6 The Leukemia & L...in Gap Inc.,s Give & Get program, which in its...garnered more than $1 million to support LLS,s blo...nd support services. ,, During the campaign, takin...issue downloadable 30% discount coupons partic...
(Date:11/6/2009)...SHINGTON, Nov. 6 The U.S. Department of Veterans ...e nation,s capital to signal the beginning of a ne...ness in five years. ,, More than 1,300 VA clinicia... federal agencies invested in providing support fo... and faith-based service providers represented by ...
Breaking Medicine News(10 mins):Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:VA Summit Frames Plan to End Veteran Homelessness 2
...que for checking the spread of cancer of the oesop...er of the oesophagus - the tube leading from the t...in the UK, making it the eighth most common cancer...ed by the cancer.// Researchers at the Unive...
... researchers, adding vitamin D to oestrogen and pr... bone density.It is already well established that ...sterone helps prevent osteoporosis in women past t...ensity in the spine by five per cent and in the hi...
... England are trialling the first long-acting male ...The drug, which is injected every three months, is... are injected with a dose of progesterone, then a ... in UK says the technique works by putting the tes...
...g with smokers have a relatively poor diet, which ...s been estimated that second-hand smoke accounts f...eople are exposed to passive smoking - usually bec...nia State University, showed in their new survey, ...
... a study, loss of muscle is not an inevitable cons...ke new muscle protein fast enough and thereby lose...niversity of California shows that muscle protein ... age 28.// Yet decreases in muscle strength ...
...sleep apnoea (shortness of breath) experience a gr... hip replacement. In sleep apnoea - which is most ...f the throat relax during sleep and so obstruct th...ed 80 patients with sleep apnoea, and 70 with norm...
Other Medicine News:
...ight system with streamlined therapeutic capacitie...sity (50 mW/cm) of its elder brother Excilite, but...ssesses the latest in technology, in order to sati...tem is fitted with additional screens which may be...
...gle wavelength of 1064nm, available in two version... W or 100 W, and it is a valid ally in all-mini-in...sical version of Smart1064 family and it is the mo...d like to have a versatile system for interdiscipl...
SmartLipo
Hiro 1.0
Medicine Products: